期刊文献+

肺泡Ⅱ型上皮细胞抗原黏蛋白在胰腺导管癌中的表达及其临床意义

KL-6 mucin expression in pancreatic ductal carcinoma and its clinical significance
原文传递
导出
摘要 目的 检测肺泡Ⅱ型上皮细胞抗原(KL-6)黏蛋白(Mucin)在胰腺导管癌中的表达水平,探讨其在胰腺癌诊断和预后评估中的临床意义.方法 38例胰腺癌患者标本采用免疫组织化学染色的方法检测胰腺癌组织标本KL-6 Mucin的表达.结果 38例胰腺导管癌标本的免疫组织化学结果显示,KL-6 Mucin均呈阳性表达(100%),78.9%表达为强阳性,72.3%的癌周胰腺组织未见KL-6 Mucin的强阳性表达.KL-6 Mucin的阳性表达与肿瘤的发展与分化呈正相关.结论 胰腺导管癌中KL-6 Mucin多呈强阳性表达,而癌周胰腺组织内表达不明显,这表明KL-6 Mucin和胰腺癌的浸润行为相关. Objective To investigate the expression of KL-6 mucin in pancreatic ducatal tissue,and to explore its clinical significance.Methods All specimens form 38 patients who were diagnosed as pancreatic ductal adenocarcinoma were subjected to immunohistochemical analysis using KL-6 monoclonal antibody.Results 100% specimens of pancreatic adenocarcinoma were found positive staining,and marked positive staining was 78.9%,remarkable positive staining was not found in the surrounding noncancer regions of the pancreatic tissues (72.3%).KL-6 mucin expression was statistical significance with the tumor development and differentiation.Conclusion Most of all pancreatic adenocarcinoma cases showed remarkable positive staining for KL-6 mucin,while the majority of surrounding non-cancer regions did not.The aberrant expression of KL-6 mucin is significantly related to aggressive tumor behaviors of pancreatic adenocarcinoma.KL-6 mucin may be a specific target to detect the pancreatic adenocarcinoma in molecular imaging study.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2014年第1期36-37,共2页 Chinese Journal of Experimental Surgery
关键词 胰腺导管癌 肺泡Ⅱ型上皮细胞抗原黏蛋白 免疫组织化学 Pancreatic ductal adenocarcinoma KL-6 mucin Immunohistochemical
  • 相关文献

参考文献4

  • 1赵晓娇,姚玮艳,袁耀宗.MUC1在胰腺癌早期诊断与治疗中的研究进展[J].国际消化病杂志,2009,29(5):328-330. 被引量:3
  • 2Hollingsworth MA,Swanson BJ. Mucins in cancer:protection and control of the cell surface[J].Nature Rev,2004,(1):45-60.
  • 3Xu HL,Inagaki Y,Seyama Y. Expression of KL-6 mucin,a human MUC1 mucin,in intrahepatic cholangiocarcinoma and its potential involvement in tumor cell adhesion and invasion[J].{H}Life Sciences,2009,(9-10):395-400.
  • 4Inagaki Y,Xu H,Nakata M. Clinicopathology of siMomucin:M UC 1,particularly KL-6 mucin,in gastrointestinal,hepatic and pancreatic cancers[J].Biosci Trends,2009,(6):220-232.

二级参考文献20

  • 1高志强,丁志强,陈勇军,李晓云,罗强,陈忠.胰腺癌组织黏蛋白MUC_1表达的意义[J].世界华人消化杂志,2006,14(9):923-926. 被引量:8
  • 2吴文川,靳大勇,秦新裕,楼文晖,王单松,倪晓凌,吴肇汉.GM-CSF增强胰腺癌MUC1-VNTR核酸疫苗免疫效果的研究[J].中华肝胆外科杂志,2006,12(7):467-470. 被引量:3
  • 3Ciborowski P, Finn OJ. Non-glycosylated tandem repeats of MUCI facilitate attachment of breast tumor cells to normal human lung tissue and immobilized extracellular matrix proteins (ECM)in vitro:potential role in metastasis. Clin Exp Metasta sis, 2002, 19: 339-345.
  • 4Hey NA, Meseguer M, Simon C, et al. Transmembrane and truncated(SEC) isoforms of MUC 1 in the human endometrium and Fallopian tube. Reprod Biol Endocrinol, 2003, 1 : 2.
  • 5Li Q, Ren J, Kufe D. Interaction of human MUC1 and β-catenin is regulated by Lek and ZAP 70 in activated Jurkat T cells.Biochem Biophys Res Commun, 2004, 315:471 -476.
  • 6Stepensky D, Tzehoval E, Vadai E, et al. O-glycosylated versus non-glycosylated MUC1-derived peptides as potential targets for cytotoxic immunotherapy of carcinoma. Clin Exp Immunol, 2006, 143:139- 149.
  • 7Ringel J, Lohr M. The MUC gene family: their role in diagnosis and early detection of pancreatic cancer. Mol Cancer, 2003, 2:9.
  • 8Burke PA, Gregg JP, Bakhtiar B, et al. Characterization of MUC1 glycoprotein on prostate cancer for selection of targeting molecules. Int J Oncol, 2006, 29: 49-55.
  • 9Tinder TL, Subramani DB, Basu GD, et al. MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocareinoma. J lmmunol, 2008, 181: 3116-3125.
  • 10Bara J, Forgue-Lafitte ME. Cytoplasmic MUC1 in PanlN-1. Clin Cancer Res, 2008, 14: 5306-5307.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部